| | | |
Mean Interval (± S.D)
| |
|---|
|
Variable
|
Baseline
|
Pre-ingestion
|
2 h-post ingestion
|
4 h-post ingestion
|
6-h post ingestion
|
|
Control
| | | | | |
|
Total cholesterol (mmol/L)
|
3.74 ± 0.99
|
3.07 ± 1.2
|
3.63 ± 1.23
|
3.81 ± 0.42
|
3.75 ± 0.62
|
|
LDL cholesterol (mmol/L)
|
2.21 ± 0.67
|
1.88 ± 0.48
|
1.83 ± 0.57
|
1.91 ± 0.39
|
2.02 ± 0.3
|
|
HDL cholesterol (mmol/L)
|
1.15 ± 0.35
|
0.92 ± 0.65
|
1.16 ± 0.43
|
1.27 ± 0.55
|
1.22 ± 0.45
|
|
triglycerides (mmol/L)
|
0.68 ± 0.23
|
0.55 ± 0.26
|
1.14 ± 0.22
|
1.40 ± 0.70
|
0.87 ± 0.19
|
|
CRP (mg/L)
|
1.24 ± 1.28
|
0.71 ± 0.39
|
0.92 ± 0.65
|
0.95 ± 0.87
|
1.19 ± 1.25
|
|
glucose (mmol/L)
|
5.06 ± 0.38
|
4.9 ± 0.28
|
4.51 ± 0.24
|
5.06 ± 0.18
|
N/A
|
|
LOOH (μM)
|
1.52 ± 0.39
|
2.26 ± 1.10
|
2.13 ± 0.91*
|
2.46 ± 1.20*
|
1.77 ± 0.8
|
|
Systolic BP (mmHg)
|
128 ± 3.2
|
129.8 ± 8.6
|
132.9 ± 6.8
|
130.5 ± 5.0
|
N/A
|
|
Diastolic BP (mmHg)
|
76.6 ± 6.1
|
76.2 ± 9.1
|
75.7 ± 5.9
|
73.5 ± 7.9
|
N/A
|
|
Exercise
| | | | | |
|
Total cholesterol (mmol/L)
|
3.93 ± 0.91
|
3.63 ± 1.02
|
4.06 ± 0.92
|
3.73 ± 1.11
|
3.58 ± 1.25
|
|
LDL cholesterol (mmol/L)
|
2.37 ± 0.64
|
2.25 ± 0.71
|
2.08 ± 0.49
|
2.01 ± 0.54
|
2.09 ± 0.66
|
|
HDL cholesterol (mmol/L)
|
1.16 ± 0.33
|
1.07 ± 0.26
|
1.18 ± 0.36
|
1.04 ± 0.48
|
1.00 ± 0.47
|
|
triglycerides (mmol/L)
|
0.68 ± 0.24
|
0.51 ± 0.23
|
1.18 ± 0.24
|
0.93 ± 0.46
|
0.66 ± 0.27
|
|
CRP (mg/L)
|
1.28 ± 0.85
|
1.08 ± 0.83
|
1.26 ± 0.88
|
1.24 ± 0.83
|
1.26 ± 0.88
|
|
glucose (mmol/L)
|
4.95 ± 0.29
|
4.59 ± 0.26†
|
4.76 ± 0.41
|
4.98 ± 0.27
|
N/A
|
|
LOOH (μM)
|
1.19 ± 0.25
|
0.97 ± 0.36
|
2.28 ± 0.90†
|
2.13 ± 1.19
|
1.44 ± 0.57
|
|
Systolic BP (mmHg)
|
131.4 ± 4.5
|
130.1 ± 4.7
|
131.8 ± 4.9
|
135 ± 6.3
|
N/A
|
|
Diastolic BP (mmHg)
|
76.8 ± 6.8
|
73.9 ± 7.8
|
70.9 ± 4.9
|
77.6 ± 5.6
|
N/A
|
- * P = < 0.05 vs. baseline control trial; † P = < 0.05 vs. baseline exercise trial
- Re: triglycerides n = 7 subjects as an outlier was removed
